Although Baycol has now been recalled from the U.S. market,
it was a prescription-only drug designed to lower cholesterol.
Baycol is one of a class of drugs called statins, which lower
cholesterol by blocking one of the body's enzymes that synthesizes
Baycol was first approved for use in the United States in
1997. Since that time, it has been used by approximately
700,000 people in the United States, and over 6 million worldwide.
In August, 2001, the manufacturer of Baycol, Bayer Pharmaceutical,
withdrew the drug from the market due to over 100 deaths and
numerous debilitating ailments linked to Rhabdomyolysis.
Rhabdomyolysis is a serious and sometimes fatal illness that
causes muscle cells to breakdown, then release the muscle's
contents directly into the bloodstream. Symptoms include weakness,
tenderness, fever, dark urine, muscle pain, nausea and vomiting.
The most affected areas of the body are the lower back and
calves. In certain cases, patients develop renal or
other organ failure, which could result in death.
According to the FDA (Federal Drug Administration), the two
groups most at risk of Rhabdomyolysis are the elderly, and
those using Baycol in conjunction with the drug, Gemifibrozil.
National lawsuits have been filed against Bayer, GlaxoSmithKline
and others in 50 federal courts. These lawsuits cite
the recent deaths and injuries caused by Baycol.
If you or someone you care about has been taking Baycol and
experienced any symptoms of Rhabdomyolysis, a cash award may
be obtainable. Fill out our questionnaire
to obtain a free consultation and find out what your case is worth.
To find out more about other cases we handle, select another
case type on your left.